BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 32669492)

  • 1. Ceftriaxone-associated Pseudolithiasis in the Gallbladder and Bile Duct of an Elderly Patient.
    Yamabe A; Irisawa A; Wakabayashi H; Tsunoda T; Tominaga K
    Intern Med; 2020 Nov; 59(21):2725-2728. PubMed ID: 32669492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults.
    Yoshida R; Yoshizako T; Katsube T; Kitagaki H
    Jpn J Radiol; 2019 Dec; 37(12):826-831. PubMed ID: 31654330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Ceftriaxone-Associated Pseudolithiasis in Adults.
    Matsumi A; Tomoda T; Terasawa H; Fujii Y; Yamazaki T; Uchida D; Matsumoto K; Horiguchi S; Tsutsumi K; Kato H
    Digestion; 2023; 104(4):313-319. PubMed ID: 36907172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases].
    Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of ceftriaxone-associated pseudolithiasis in an adult patient that disappeared after the discontinuation of ceftriaxone].
    Tomoda T; Ueki T; Saito S; Tatsukawa M; Nawa T; Hamamoto H; Endo H; Yabushita K; Shimoe T; Sakaguchi K
    Nihon Shokakibyo Gakkai Zasshi; 2013 Aug; 110(8):1481-6. PubMed ID: 23912008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden-onset gallbladder rupture due to Ceftriaxone-associated pseudolithiasis in a patient with acquired hemophilia A.
    Harada N; Shibano I; Mukai D; Kizawa Y; Shiragami H; Takayanagi S; Hosaka N; Mugitani A; Hino M
    J Infect Chemother; 2023 Aug; 29(8):796-799. PubMed ID: 37075980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone-associated gallbladder pseudolithiasis in a PD patient.
    Rivera M; García-Herrera AL; Burguera V; Sosa-Barrios H; Palomares JR; Quereda C
    Perit Dial Int; 2011; 31(1):97-9. PubMed ID: 21282390
    [No Abstract]   [Full Text] [Related]  

  • 8. Ceftriaxone-associated acute gallbladder enlargement - an unexpected diagnosis in the child with urinary tract infection.
    Krzemień G; Książczyk T; Szmigielska A; Bombiński P; Roszkowska-Blaim M; Werner B; Brzewski M
    Dev Period Med; 2015; 19(2):182-5. PubMed ID: 26384120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CEFTRIAXONE-INDUCED GALLBADDER LITHIASIS IN CASE OF INTENSTINAL BACTERIAL INFECTIONS (CASE REPORTS)].
    Khotchava M; Lashkhi E; Jokhtaberidze T; Shalamberidze I
    Georgian Med News; 2016 Jan; (250):72-5. PubMed ID: 26870979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical review and case report of ceftriaxone-associated gallbladder pseudolithiasis in adult].
    Jung HK; Lee DS
    Korean J Gastroenterol; 2014 Jun; 63(6):378-81. PubMed ID: 24953617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children.
    Ozturk A; Kaya M; Zeyrek D; Ozturk E; Kat N; Ziylan SZ
    Acta Radiol; 2005 Feb; 46(1):112-6. PubMed ID: 15841750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone-associated Pseudolithiasis in Elderly People: Frequency and Risk Factors.
    Hotta K; Hashimura N; Takatsuka M; Matsuyama T; Nakagawa K; Yabusako T; Hosomi S; Fujiwara Y
    Intern Med; 2021; 60(24):3857-3864. PubMed ID: 34911872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study.
    Acun C; Erdem LO; Söğüt A; Erdem CZ; Tomaç N; Gündoğdu S; Cavuldak S
    Ann Trop Paediatr; 2004 Mar; 24(1):25-31. PubMed ID: 15005963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone-associated Biliary Pseudolithiasis with Elderly Type 1 Diabetes Mellitus: Two Case Reports.
    Kanazawa K; Suzuki S; Inaba T; Koga S; Kuwabara K
    Intern Med; 2023 Nov; 62(22):3367-3371. PubMed ID: 37032086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.
    Murata S; Aomatsu T; Yoden A; Tamai H
    Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
    Prince JS; Senac MO
    Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis.
    de Moor RA; Egberts AC; Schröder CH
    Eur J Pediatr; 1999 Dec; 158(12):975-7. PubMed ID: 10592073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone-associated biliary pseudolithiasis.
    Rienstra M; Bonten MJ; Gaillard CA
    Neth J Med; 2009 Mar; 67(3):113-4. PubMed ID: 19307687
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.
    Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y
    Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
    Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
    Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.